patentlitigation.ch

This is a recording of the LinkedIn Audio session of 27 July 2022 (without the follow-up discussions with the audience). The following topics are covered: 1️⃣ S2022_001 (register ban in entitlement proceedings) 2️⃣ 4A_41/2022 (on appeal against O2020_002; JDE ./. Delica) 3️⃣ 4A_11/2022 (on appeal against O2019_007; MGI ./. Illumina) 4️⃣ Ulrich Meyer's recent guest comment in the NZZ Neue Zürcher Zeitung, https://lnkd.in/eKh7Dxx9

This is an audio recording of the LinkedIn Live session of 29 June 2022. The following topics are covered: 👉S2022_002 Novartis ./. Mepha Pharma Order of 2 June 2022: ‘Fingolimod 0.5 mg’ 👉O2020_004 (the aftermath) yodoba AG ./. Swisscom (Schweiz) AG Rumour has it … 👉INGRES Some take-aways from the event of 23 June 2022

This is an audio recording of the LinkedIn Live session of 1 June 2022. It covers the following topics: 👉S2022_001 Pelliheat AG ./. Hans SCHÄREN Judgment of 2 March 2022: 'Register ban' 👉O2020_004 yodoba AG ./. Swisscom (Schweiz) AG Judgment of 22 March 2022: 'Swisscom TV 2.0' 👉S2021_006 Bayer HealthCare LLC ./. Helvepharm AG Judgment of 26 April 2022: 'Sorafenib tosylate' 👉The FPC's 10th Anniversary Symposium of 6 May 2022: A quick recap 👉Art. 84 EPC Claims shall «be supported by the description» ...

Decision G 1/19 of the Enlarged Board of Appeal has been published on 10 March 2021. The decision is not only of relevance for computer-implemented simulations, but rather for all kinds of mixed inventions. G 1/19 carves the COMVIK approach (T 641/00) in stone - and stops short of saying that the former lead case in the field of computer-implemented simulation, T 1227/05 (Infineon), came to the wrong conclusion.